Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8EWX
DownloadVisualize
BU of 8ewx by Molmil
N-terminal WD40 domain of beta'-COPI subunit with two chains in the asymmetric unit
Descriptor: Coatomer subunit beta'
Authors:Dey, D, Hasan, S.S.
Deposit date:2022-10-24
Release date:2023-08-30
Last modified:2023-10-04
Method:X-RAY DIFFRACTION (1.24 Å)
Cite:Strategies for rapid production of crystallization quality coatomer WD40 domains.
Protein Expr.Purif., 212, 2023
8ENZ
DownloadVisualize
BU of 8enz by Molmil
Crystal structure of alpha-COPI-WD40 domain K15A mutant.
Descriptor: ACETYL GROUP, Putative coatomer subunit alpha
Authors:Dey, D, Hasan, S.S.
Deposit date:2022-09-30
Release date:2024-01-31
Method:X-RAY DIFFRACTION (1.65 Å)
Cite:A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Nat Commun, 14, 2023
8ENY
DownloadVisualize
BU of 8eny by Molmil
Crystal structure of alpha-COPI-WD40 domain R13A mutant.
Descriptor: ACETYL GROUP, Putative coatomer subunit alpha
Authors:Dey, D, Hasan, S.S.
Deposit date:2022-09-30
Release date:2024-01-31
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Nat Commun, 14, 2023
8ENX
DownloadVisualize
BU of 8enx by Molmil
Crystal structure of beta'-COPI-WD40 domain Y33A mutant in complex with SARS-CoV-2 clientized spike tail heptapeptide.
Descriptor: Clientized spike tail heptapeptide, Coatomer subunit beta'
Authors:Dey, D, Hasan, S.S.
Deposit date:2022-09-30
Release date:2024-01-31
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Nat Commun, 14, 2023
8EO0
DownloadVisualize
BU of 8eo0 by Molmil
Crystal structure of alpha-COPI WD40 domain R300A mutant.
Descriptor: ACETYL GROUP, Putative coatomer subunit alpha
Authors:Dey, D, Hasan, S.S.
Deposit date:2022-10-01
Release date:2024-01-31
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Nat Commun, 14, 2023
8ENS
DownloadVisualize
BU of 8ens by Molmil
Crystal structure of beta'-COPI-WD40 domain in complex with SARS-CoV-2 spike tail hepta-peptide
Descriptor: Coatomer subunit beta', spike tail hepta-peptide
Authors:Dey, D, Hasan, S.S.
Deposit date:2022-09-30
Release date:2024-01-31
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Nat Commun, 14, 2023
8ENW
DownloadVisualize
BU of 8enw by Molmil
Crystal structure of beta'-COPI-WD40 domain in complex with SARS-CoV-2 clientized spike tail heptapeptide.
Descriptor: 1,2-ETHANEDIOL, Clientized spike tail peptide, Coatomer subunit beta'
Authors:Dey, D, Hasan, S.S.
Deposit date:2022-09-30
Release date:2024-01-31
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Nat Commun, 14, 2023
8G3C
DownloadVisualize
BU of 8g3c by Molmil
Crystal structure of human WDR5 in complex with N-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-3-hydroxy-6-methyl-4-oxo-4H-pyran-2-carboxamide (compound 1, WDR5-MYC PPI inhibitor)
Descriptor: N-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-3-hydroxy-6-methyl-4-oxo-4H-pyran-2-carboxamide, WD repeat-containing protein 5
Authors:Zhao, M.
Deposit date:2023-02-07
Release date:2023-06-28
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction.
J.Med.Chem., 66, 2023
8G3E
DownloadVisualize
BU of 8g3e by Molmil
Crystal structure of human WDR5 in complex with (1M)-N-[(3,5-difluoro[1,1'-biphenyl]-4-yl)methyl]-6-methyl-4-oxo-1-(pyridin-3-yl)-1,4-dihydropyridazine-3-carboxamide (compound 2, WDR5-MYC inhibitor)
Descriptor: (1M)-N-[(3,5-difluoro[1,1'-biphenyl]-4-yl)methyl]-6-methyl-4-oxo-1-(pyridin-3-yl)-1,4-dihydropyridazine-3-carboxamide, WD repeat-containing protein 5
Authors:Zhao, M.
Deposit date:2023-02-07
Release date:2023-06-28
Last modified:2023-10-25
Method:X-RAY DIFFRACTION (1.33 Å)
Cite:Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction.
J.Med.Chem., 66, 2023
7SI5
DownloadVisualize
BU of 7si5 by Molmil
CRYSTAL STRUCTURE OF EED WITH MRTX-1919
Descriptor: (4R)-8-(1,3-dimethyl-1H-pyrazol-5-yl)-5-{[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]amino}imidazo[1,2-c]pyrimidine-2-carbonitrile, 1,2-ETHANEDIOL, FORMIC ACID, ...
Authors:Gunn, R.J, Burns, A.C, Lawson, J.D, Marx, M.A.
Deposit date:2021-10-12
Release date:2022-11-09
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (1.75 Å)
Cite:CRYSTAL STRUCTURE OF EED WITH MRTX-1919
TO BE PUBLISHED
7SI4
DownloadVisualize
BU of 7si4 by Molmil
CRYSTAL STRUCTURE OF EED WITH MRTX-2219
Descriptor: (4S)-8-{4-[(dimethylamino)methyl]-2-methylphenyl}-5-{[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]amino}imidazo[1,2-c]pyrimidine-2-carbonitrile, FORMIC ACID, Polycomb protein EED
Authors:Gunn, R.J, Burns, A.C, Lawson, J.D, Marx, M.A.
Deposit date:2021-10-12
Release date:2022-11-09
Last modified:2023-10-18
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:CRYSTAL STRUCTURE OF EED WITH MRTX-2219
TO BE PUBLISHED
7U9Y
DownloadVisualize
BU of 7u9y by Molmil
WDR5 bound to 2-(3,5-dimethoxybenzyl)-7-((2-methyl-1H-imidazol-1-yl)methyl)-5-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)-3,4-dihydroisoquinolin-1(2H)-one
Descriptor: (5P)-2-[(3,5-dimethoxyphenyl)methyl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3,4-dihydroisoquinolin-1(2H)-one, BENZAMIDINE, WD repeat-containing protein 5
Authors:Rietz, T.
Deposit date:2022-03-11
Release date:2022-04-27
Last modified:2023-10-18
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.
J.Med.Chem., 65, 2022
7UAS
DownloadVisualize
BU of 7uas by Molmil
Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization
Descriptor: (5P)-2-[(S)-cyclopropyl(4-methylpyridin-2-yl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one, WD repeat-containing protein 5
Authors:Zhao, B.
Deposit date:2022-03-14
Release date:2022-05-04
Last modified:2023-10-18
Method:X-RAY DIFFRACTION (1.808 Å)
Cite:Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.
J.Med.Chem., 65, 2022
8SHJ
DownloadVisualize
BU of 8shj by Molmil
Crystal structure of the WD-repeat domain of human WDR91 in complex with MR45279
Descriptor: N-[3-(4-chlorophenyl)oxetan-3-yl]-4-[(3S)-3-hydroxypyrrolidin-1-yl]benzamide, WD repeat-containing protein 91
Authors:Ahmad, H, Zeng, H, Dong, A, Li, Y, Hutchinson, A, Seitova, A, Xu, J, Feng, J.W, Brown, P.J, Ackloo, S, Arrowsmith, C.H, Edwards, A.M, Halabelian, L, Structural Genomics Consortium (SGC)
Deposit date:2023-04-14
Release date:2023-07-05
Last modified:2024-05-01
Method:X-RAY DIFFRACTION (2.21 Å)
Cite:Discovery of a First-in-Class Small-Molecule Ligand for WDR91 Using DNA-Encoded Chemical Library Selection Followed by Machine Learning.
J.Med.Chem., 66, 2023
8SIU
DownloadVisualize
BU of 8siu by Molmil
Origin Recognition Complex Associated (ORCA) protein bound to Orc2
Descriptor: Leucine-rich repeat and WD repeat-containing protein 1, Origin recognition complex subunit 2, SULFATE ION
Authors:Bleichert, F, Ekundayo, B.E.
Deposit date:2023-04-17
Release date:2023-08-02
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:A dual role for the chromatin reader ORCA/LRWD1 in targeting the origin recognition complex to chromatin.
Embo J., 42, 2023
8T55
DownloadVisualize
BU of 8t55 by Molmil
Co-crystal structure of the WD-repeat domain of human WDR91 in complex with MR46654
Descriptor: 1,2-ETHANEDIOL, N-[3-(4-chlorophenyl)oxetan-3-yl]-1-propanoyl-1,2,3,4-tetrahydroquinoline-5-carboxamide, WD repeat-containing protein 91
Authors:Ahmad, H, Zeng, H, Dong, A, Li, Y, Yen, H, Seitova, A, Xu, J, Feng, J.W, Brown, P.J, Santhakumar, V, Ackloo, S, Arrowsmith, C.H, Edwards, A.M, Halabelian, L, Structural Genomics Consortium (SGC)
Deposit date:2023-06-12
Release date:2023-07-05
Last modified:2024-05-01
Method:X-RAY DIFFRACTION (2.2 Å)
Cite:Discovery of a First-in-Class Small-Molecule Ligand for WDR91 Using DNA-Encoded Chemical Library Selection Followed by Machine Learning.
J.Med.Chem., 66, 2023
8T5I
DownloadVisualize
BU of 8t5i by Molmil
Crystal structure of human WDR5 in complex with MR4397
Descriptor: 1,2-ETHANEDIOL, DI(HYDROXYETHYL)ETHER, N-[(2S)-1-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-1-oxopentan-2-yl]-3-[(1H-imidazol-1-yl)methyl]benzamide, ...
Authors:Kimani, S, Dong, A, Li, F, Loppnau, P, Ackloo, S, Vedadi, M, Brown, P.J, Arrowsmith, C.H, Edwards, A.M, Halabelian, L, Structural Genomics Consortium (SGC)
Deposit date:2023-06-13
Release date:2023-08-09
Last modified:2024-05-22
Method:X-RAY DIFFRACTION (1.7 Å)
Cite:Crystal structure of human WDR5 in complex with MR4397
To be published
8SZX
DownloadVisualize
BU of 8szx by Molmil
Crystal structure of b'-WD40 Lys17Ala mutant
Descriptor: Coatomer subunit beta'
Authors:Dey, D, Hasan, S.S.
Deposit date:2023-05-30
Release date:2024-02-14
Method:X-RAY DIFFRACTION (2 Å)
Cite:A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Nat Commun, 14, 2023
8UJY
DownloadVisualize
BU of 8ujy by Molmil
Crystal structure of human WD repeat-containing protein 5 in complex with 4-(3,5-dimethoxybenzyl)-9-(4-fluoro-2-methylphenyl)-7-((2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl)methyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one (compound 8)
Descriptor: (9P)-4-[(3,5-dimethoxyphenyl)methyl]-9-(4-fluoro-2-methylphenyl)-7-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-3,4-dihydro-1,4-benzoxazepin-5(2H)-one, WD repeat-containing protein 5
Authors:Zhao, B, Amporndanai, K, Fesik, S.W.
Deposit date:2023-10-11
Release date:2023-12-20
Last modified:2024-01-10
Method:X-RAY DIFFRACTION (2.01 Å)
Cite:Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors.
J.Med.Chem., 66, 2023
8Q1N
DownloadVisualize
BU of 8q1n by Molmil
Cyclic peptide binder of the WBM-site of WDR5
Descriptor: Cyclic peptide inhibitor, WD repeat-containing protein 5
Authors:Schmeing, S, Chang, J.Y, t Hart, P, Gasper, R.
Deposit date:2023-08-01
Release date:2023-09-06
Last modified:2023-09-13
Method:X-RAY DIFFRACTION (1.843 Å)
Cite:Macrocyclic peptides as inhibitors of WDR5-lncRNA interactions.
Chem.Commun.(Camb.), 59, 2023
8WXU
DownloadVisualize
BU of 8wxu by Molmil
Structure of WDR5 in complex with WIN motif containing MBD3C C44S/R45E/V46G
Descriptor: MBD3C, WD repeat-containing protein 5
Authors:Xu, L, Yang, Y.
Deposit date:2023-10-30
Release date:2024-06-26
Last modified:2024-07-17
Method:X-RAY DIFFRACTION (2.37 Å)
Cite:Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode.
J.Biol.Chem., 300, 2024
8WXR
DownloadVisualize
BU of 8wxr by Molmil
Structure of WDR5 in complex with WIN motif containing MBD3C F47A
Descriptor: MBD3C, WD repeat-containing protein 5
Authors:Xu, L, Yang, Y.
Deposit date:2023-10-30
Release date:2024-06-26
Last modified:2024-07-17
Method:X-RAY DIFFRACTION (2.08 Å)
Cite:Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode.
J.Biol.Chem., 300, 2024
8WXV
DownloadVisualize
BU of 8wxv by Molmil
Structure of WDR5 in complex with WIN motif containing SET1B
Descriptor: SET1B, WD repeat-containing protein 5
Authors:Xu, L, Yang, Y.
Deposit date:2023-10-30
Release date:2024-06-26
Last modified:2024-07-17
Method:X-RAY DIFFRACTION (2.4 Å)
Cite:Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode.
J.Biol.Chem., 300, 2024
8WXQ
DownloadVisualize
BU of 8wxq by Molmil
Structure of WDR5 in complex with WIN motif containing MBD3C
Descriptor: GLY-ALA-ALA-ARG-CYS-ARG-VAL-PHE-SER-PRO, WD repeat-containing protein 5
Authors:Xu, L, Yang, Y.
Deposit date:2023-10-30
Release date:2024-06-26
Last modified:2024-07-17
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode.
J.Biol.Chem., 300, 2024
8X3S
DownloadVisualize
BU of 8x3s by Molmil
Crystal structure of human WDR5 in complex with PTEN
Descriptor: Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, WD repeat-containing protein 5
Authors:Liu, Y, Huang, X, Shang, X.
Deposit date:2023-11-14
Release date:2024-05-29
Method:X-RAY DIFFRACTION (1.87 Å)
Cite:The NTE domain of PTEN alpha / beta promotes cancer progression by interacting with WDR5 via its SSSRRSS motif.
Cell Death Dis, 15, 2024

222624

PDB entries from 2024-07-17

PDB statisticsPDBj update infoContact PDBjnumon